| Veröffentlichte Version Download ( PDF | 1MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution
Forster, Lisa und Pockes, Steffen
(2022)
Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.
Scientific Reports 12 (1).
Veröffentlichungsdatum dieses Volltextes: 21 Jun 2022 05:22
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.52431
Zusammenfassung
The signalling of the D-2 receptor (D2R), a G protein-coupled receptor (GPCR), is a complex process consisting of various components. For the screening of D2R ligands, methods quantifying distinct second messengers such as cAMP or the interaction of the receptor with p-arrestin, are commonly employed. In contrast, a label-free biosensor technology like dynamic mass redistribution (DMR), where it ...
The signalling of the D-2 receptor (D2R), a G protein-coupled receptor (GPCR), is a complex process consisting of various components. For the screening of D2R ligands, methods quantifying distinct second messengers such as cAMP or the interaction of the receptor with p-arrestin, are commonly employed. In contrast, a label-free biosensor technology like dynamic mass redistribution (DMR), where it is mostly unknown how the individual signalling pathways contribute to the DMR signal, provides a holistic readout of the complex cellular response. In this study, we report the successful application of the DMR technology to CHO-Kl cells stably expressing the human dopamine D-2(long) receptor. In real-time kinetic experiments, studies of D2R reference compounds yielded results for agonists and antagonists that were consistent with those obtained by conventional methods and also allowed a discrimination between partial and full agonists. Furthermore, investigations on the signalling pathway in CHO-K1 hD(2long) cells identified the G alpha(i/o) protein as the main proximal trigger of the observed DMR response. The present study has shown that the DMR technology is a valuable method for the characterisation of putative new ligands and, due to its label-free nature, suggests its use for deorphanisation studies of GPCRs.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Scientific Reports | ||||
| Verlag: | Nature | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | BERLIN | ||||
| Band: | 12 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 1 | ||||
| Datum | 10 Juni 2022 | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | PROTEIN-COUPLED RECEPTORS; CELL-BASED ASSAYS; DOPAMINE-RECEPTOR; ADENYLYL-CYCLASE; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; ANTIPSYCHOTIC-DRUGS; OPTICAL BIOSENSOR; MULTIPLE CLASSES; | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-524319 | ||||
| Dokumenten-ID | 52431 |
Downloadstatistik
Downloadstatistik